Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for SepsisChristopher Seymour, Derek C. Angus, Hernando Gómez et al.|JAMA|2019Cited by 1.5k
Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis*Derek C. Angus, Ben van Hout, Walter T. Linde‐Zwirble et al.|Critical Care Medicine|2003Cited by 226
Assessment of Dynamic Intracranial Compliance in Children with Severe Traumatic Brain Injury: Proof-of-ConceptRobert S. B. Clark, Jaskaran Rakkar, Christopher M. Horvat et al.|Neurocritical Care|2020Cited by 18
Pediatric Sepsis Phenotype in a Single-Center Cohort Covering 2010–2020: Evolution in Day 1–Day 3 Trajectory and Potential Prognostic ValueZachary Aldewereld, Gilles Clermont, Christopher M. Horvat|Pediatric Critical Care Medicine|2025Cited by 6
EMERGENCE OF A TECHNOLOGY-DEPENDENT PHENOTYPE OF PEDIATRIC SEPSIS IN A LARGE CHILDREN'S HOSPITALZachary Aldewereld, Gilles Clermont, Christopher M. Horvat et al.|Shock|2023Cited by 3